End	O
points	O

The	O
primary	O
endpoints	O
were	O
the	O
achievement	B-PrimaryOutcome
of	I-PrimaryOutcome
two	I-PrimaryOutcome
successive	I-PrimaryOutcome
negative	I-PrimaryOutcome
SARS	I-PrimaryOutcome
-	I-PrimaryOutcome
CoV	I-PrimaryOutcome
-	I-PrimaryOutcome
2	I-PrimaryOutcome
PCR	I-PrimaryOutcome
analysis	I-PrimaryOutcome
tests	I-PrimaryOutcome
48	B-TimeFrame
h	I-TimeFrame
apart	I-TimeFrame
by	O
nasopharyngeal	O
swab	O
,	O
normalization	B-PrimaryOutcome
of	I-PrimaryOutcome
body	I-PrimaryOutcome
temperature	I-PrimaryOutcome
for	B-TimeFrame
48	I-TimeFrame
h	I-TimeFrame
,	O
improvement	B-PrimaryOutcome
of	I-PrimaryOutcome
radiological	I-PrimaryOutcome
abnormalities	I-PrimaryOutcome
at	B-TimeFrame
Day	I-TimeFrame
14	I-TimeFrame
and	O
the	O
hospital	B-PrimaryOutcome
discharge	I-PrimaryOutcome
rate	I-PrimaryOutcome
.	O

The	O
secondary	O
endpoints	O
were	O
the	O
normalization	B-SecondaryOutcome
of	I-SecondaryOutcome
C	I-SecondaryOutcome
-	I-SecondaryOutcome
reactive	I-SecondaryOutcome
protein	I-SecondaryOutcome
(	I-SecondaryOutcome
CRP	I-SecondaryOutcome
)	I-SecondaryOutcome
and	O
serum	B-SecondaryOutcome
ferritin	I-SecondaryOutcome
levels	I-SecondaryOutcome
.	O

